Another Indian drug manufacturer hit with a Form 483 over recent observations
Several Indian drug manufacturers have been put under a microscope by the FDA, as major generics manufacturers have been hit in recent months by Form 483s. And now Dr. Reddy’s Laboratories is the latest to get the slap.
According to the Indian business news site Business Standard, Dr. Reddy’s Laboratories was served a Form 483. The form highlighted two observations after inspecting its manufacturing facility located at Srikakulam, India, a city in the east.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.